Theravance Biopharma US
Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn more.
Basic Information
- Category: business
- Website: http://www.theravance.com
Documented Facts
- Inception (Wikidata): 1996-01-01 (Source 2: Wikidata Q105169378, revision 2008385465)
- Headquarters location (Wikidata; date unspecified): South San Francisco (Source 2: Wikidata Q105169378, revision 2008385465; Source 3: Wikidata label: Q927122, revision 2553524786)
- Country (Wikidata; date unspecified): United States (Source 2: Wikidata Q105169378, revision 2008385465; Source 4: Wikidata label: Q30, revision 2556188301)
Evidence and Sources
- Theravance Biopharma US — Official Website (official)
- Wikidata Q105169378, revision 2008385465 (knowledge-base)
- Wikidata label: Q927122, revision 2553524786 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Theravance Biopharma US.
- Canonical profile: https://brandsource.ai/brands/theravance-biopharma-us
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/theravance-biopharma-us/json-ld
- Citation profile API: https://brandsource.ai/api/brands/theravance-biopharma-us/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn more.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.